本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Bone Biologics Corp

3.49
-0.1300-3.59%
盘后3.46-0.0300-0.86%16:52 EDT
成交量:13.11万
成交额:46.60万
市值:560.25万
市盈率:-0.17
高:3.65
开:3.63
低:3.49
收:3.62
数据加载中...
2024/06/28

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/06/20

重要事件披露

Form 8-K - Current report
2024/05/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/03/15

重要事件披露

Form 8-K - Current report
2024/03/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/03/06

重要事件披露

Form 8-K - Current report
2024/03/02

SEC问询函

Form CORRESP - Correspondence
2024/03/01

重要事件披露

Form 8-K - Current report
2024/03/01

SEC问询函

Form CORRESP - Correspondence
2024/02/29

SEC问询函

Form CORRESP - Correspondence
2024/02/28

SEC问询函

Form CORRESP - Correspondence
2024/02/26

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/02/23

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/02/21

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/30

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/01/23

SEC问询函

Form CORRESP - Correspondence
2024/01/13

重要事件披露

Form 8-K - Current report